Korro Bio, Inc. (KRRO)

Korro Bio, Inc. (KRRO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $141M; returns 1 day -0.6%, 1 week +41.1%, 1 year -68.1%.

Korro Bio, Inc. (NASDAQ: KRRO) is a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines through its proprietary RNA editing platform.

Groups KRRO belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biopharma
• Healthcare
• Gene Therapy
• Clinical Stage
• Rare Diseases
• Strategic Pivot
• Precision Medicine

KRRO financial model: income statement, cash flow and balance sheet